DL-6,8-THIOCTIC ACID
Neurologic Disorder
Ain Shams UniversitySmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Neurologic Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
D-thioctic acid Ain Shams University | Phase 4 | BB |
Cenobamate Brigham and Women's Hospital | Early Phase 1 | C |
Fycompa National Taiwan University Hospital | D |
Same molecule, other indications
DL-6,8-THIOCTIC ACID is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →